• 01Oct

09:201^st October
55 mins

●

Chair’s opening remarks followed by: Cardio-Oncology: Harmonizing heart and cancer care

• The impact of systemic anti-cancer therapy on the cardiovascular system
• Assessing cardiovascular risk and why it’s important
• Collaborative care and coordination of the MDT in cardio-oncology

Rebecca Dobson

Rebecca Dobson

Consultant Cardiologist (Imaging & Cardio-Oncology), Liverpool Heart and Chest Hospital

Dr Rebecca Dobson is a Consultant Cardiologist at the Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool Heart & Chest Hospital, in Liverpool, UK. She has a special interest in imaging and cardio-oncology. Dr Dobson's research interests include cardio-oncology, cardiac imaging and advanced echocardiography, including chemotherapy-induced left ventricular systolic dysfunction, cardiac disease in cancer patients, carcinoid heart disease and heart valve disease. Dr Dobson is a member of the British Cardiovascular Society, the British Cardio-Oncology Society, the British Society of Echocardiography and the Royal College of Physicians. Dr Rebecca Dobson is Section Editor of European Cardiology Review.

& Helena Beer

Helena Beer

Editor, Hospital Healthcare Europe, Hospital Pharmacy Europe

Helena is an award-winning journalist and editor specialising in healthcare. She joined Cogora as Editor of Hospital Healthcare Europe and Hospital Pharmacy Europe in April 2023 and oversees the writing, commissioning and editing of content for senior stakeholder, consultant and hospital pharmacist audiences. Covering stories on clinical, policy, strategy and professional developments, among other topics, the publications share examples of best practice and innovative ideas for addressing healthcare challenges and delivering more efficient and effective patient care across the UK and Europe. Prior to this, Helena spent many years working as a writer and editor in the community pharmacy trade press, for which she received several awards including the Professional Publishers Association (PPA) 30 Under 30 Award. She was also editor of a trade publication for the marketing and medical affairs arms of the pharmaceutical industry and has freelanced for a range of national consumer magazines. Helena is a member of the Medical Journalists’ Association.

10:301^st October
45 mins

●

Sponsored session to be confirmed

This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only. 

AstraZeneca has provided a sponsorship towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.

Sponsored by

11:301^st October
45 mins

●

Sponsored session to be confirmed

This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only. 

AstraZeneca has provided a sponsorship towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.

Sponsored by

12:301^st October
45 mins

●

The changing landscape of cardiovascular disease and the challenge of prevention

• Preventing cardiovascular disease, such as hypertension
• Risk factors and how to address them with patients
• Specific risks of CVD in diabetes, obesity and smoking

Kazem Rahimi

Kazem Rahimi

Professor of Cardiovascular Medicine and Population Health, Deep Medicine, Nuffield Department of Womens’ and Reproductive Health, University of Oxford, Honorary Consultant Cardiologist, Oxford University Hospitals NHS Trust

Kazem Rahimi is a Professor of Cardiovascular Medicine and Population Health, at the University of Oxford and a consultant cardiologist at the Oxford University Hospitals NHS Trust. His research interests include hypertension, heart failure, multimorbidity and cardiovascular risk management, using a variety of methodologies such as individual-patient meta-analysis, large-scale decentralised clinical trials, and digital health technologies.

Kazem leads the Deep Medicine programme at the Nuffield Department of Women’s and Reproductive Health with a major interest in application of machine learning approaches to electronic health records. He also leads the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC), which is an international collaboration of all the major trials of blood pressure lowering drugs. He is the Director of the Martin School programme on Informal Cities and a Co-Investigator of the PEAK-Urban programme

13:301^st October
45 mins

●

Managing ventricular arrhythmia: innovations and best practices

• Diagnosing ventricular arrhythmia
• Pharmacological and non-pharmacological treatments for management
• Indications for catheter ablation and device therapy, e.g. implantable cardioverter-defibrillators.

Dr John Whitaker

Dr John Whitaker

Senior Lecturer, Honorary Consultant Cardiologist and Electrophysiologist, King's College London, Guys and St Thomas' Foundation Trust

John Whitaker has been an honorary consultant in cardiology, electrophysiology and devices at Guy's and St Thomas' NHS Foundation Trust since 2023. He is also a clinical senior lecturer. He has experience in the assessment and management of heart arrhythmias, with a particular interest in ventricular arrhythmias.

14:301^st October
45 mins

●

Panel Discussion: Advances in interventional cardiology

• Techniques, procedures and devices currently being used
• Examples including coronary artery disease, valvular heart disease and structural heart conditions

Brian Halliday

Brian Halliday

Consultant Cardiologist, Clinical Senior Lecturer in Cardiomyopathy and CMR, BHF Intermediate Fellow, Royal Brompton and Harefield Hospitals and National Heart and Lung Institute, Imperial College London

Brian is a Clinical Senior Lecturer at the National Heart and Lung Institute, Imperial College and Honorary Consultant Cardiologist at Royal Brompton and Harefield Hospitals, Guys’ and St Thomas’ NHS Trust and BHF Intermediate Fellow,. His research and clinical interests focus on the management of patients with cardiomyopathy and the use of cardiovascular magnetic resonance to improve treatment stratification. He aims to develop patient-centred, precision treatment approaches using targeted therapies and adaptable strategies guided by in-depth characterisation of the underlying dynamic disease substrate. He is particularly interested in the concepts of myocardial recovery and remission and methods to distinguish between the two.

, Dr Pierluigi Costanzo

Dr Pierluigi Costanzo

Consultant Interventional and Structural Cardiology, Clinical Lead for Coronary Intervention, Royal Papworth Hospital NHS Foundation Trust

& Dr Alex Zaphiriou,

Dr Alex Zaphiriou,

Consultant in Interventional Cardiology, University Hospitals Birmingham- Queen Elizabeth Hospital

Alex joint Queen Elizabeth as a trainee and then as a consultant over 10 years ago He specialises in complete higher risk indicated percutaneous coronary intervention and uses a range of adjuvant technologies (LV support with Impella, rotational and LASER atherectomy). He supports the advanced heart failure and heart transplant teams and performs LV biopsies using the radial route for patients with suspected infiltrative cardiac conditions He leads the refractory angina & coronary sinus implantation service.

15:301^st October
45 mins

●

Cardiomyopathy - Diagnosis and management

• A review of the different types of cardiomyopathy
• Clinical presentations and diagnostic criteria
• Management and treatment

Brian Halliday

Brian Halliday

Consultant Cardiologist, Clinical Senior Lecturer in Cardiomyopathy and CMR, BHF Intermediate Fellow, Royal Brompton and Harefield Hospitals and National Heart and Lung Institute, Imperial College London

Brian is a Clinical Senior Lecturer at the National Heart and Lung Institute, Imperial College and Honorary Consultant Cardiologist at Royal Brompton and Harefield Hospitals, Guys’ and St Thomas’ NHS Trust and BHF Intermediate Fellow,. His research and clinical interests focus on the management of patients with cardiomyopathy and the use of cardiovascular magnetic resonance to improve treatment stratification. He aims to develop patient-centred, precision treatment approaches using targeted therapies and adaptable strategies guided by in-depth characterisation of the underlying dynamic disease substrate. He is particularly interested in the concepts of myocardial recovery and remission and methods to distinguish between the two.

16:151^st October
45 mins

●

End of conference

* We would like to thank our exhibitors for sponsoring this meeting, which includes pharmaceutical companies including AstraZeneca UK. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations. 

REGISTER NOW

What will you learn at an HHE Clinical Excellence event?

• Hear from Centres of Excellence and beyond to find out what they are doing to improve patient care
• Explore new clinical advances in areas ranging from chronic heart failure, prevention and risk factors, advances in interventional cardiology, and genetics
• Gain CPD hours
• Understand how different hospital departments are utilising multidisciplinary teams to improve patient care, which will impact your ways of working
• Pick and choose sessions most relevant to your clinical practice, specifically tailoring the day to your needs
• Catch up on-demand with recordings available free for a minimum of three months

What did your peers think of the 2023 HHE Clinical Excellence in Cardiovascular Care event?

"Good cardiology update from professionals." - Emma D'Amato, Immunology Speciality Doctor

Comprehensive and knowledgeable. I enjoyed how the subject was approached." - Andreea Gheorghiu, Emergency Nurse

"I gained new insight about treatment in cardiovascular care. I learnt how lifestyle changes of patients with cardiovascular disease can help in reducing the annual death rate." - Sunny Oginni, ICU Staff Nurse

"It was very useful and comprehensive. It updated my knowledge about many aspects of new and advanced cardiac management." - Michael Beniamin, Specialty Doctor

"It’s a great experience as a cardiothoracic sister. It helped me understand more about the different diseases and treatments. With this experience I can also teach my colleagues what I have learned in this topic." - Sharon De Vera, Sister